GSK PLC CEDEAR EACH REPR 1/4 ADRGG

GSK PLC CEDEAR EACH REPR 1/4 ADR

11,175.000ARSD
−75.000−0.67%
At close at Feb 21, 20:00 GMT
ARS
No trades
See on Supercharts

GSK PLC CEDEAR EACH REPR 1/4 ADR forum

GSK Break to the downside coming this week since an hedge order came in for 4/19 exp.

Entry below $40.51

Trade becomes invalid on any gap and go or around the $40.98 area

GSK jemperil clinical trial forecasted to be complete by end of June. It treats endometrial cancer